Last $782.80 MXN
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:09 PM 05/20/13 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - roche holdings ltd-spons adr (RHHBYN)

NameBoard RelationshipsTitleAge
Severin Schwan 31 RelationshipsChief Executive Officer and Director45
Franz B. Humer 132 RelationshipsChairman of the Board and Chairman of Presidium of the Board of Directors/Nomination Committee66
Alan Hippe 53 RelationshipsChief Financial and IT Officer45
Ian T. Clark 136 RelationshipsHead of Global Product Strategy and Chief Executive Officer of Genentech51
Hal V. Barron M.D., F.A.C.C.8 RelationshipsChief Medical Officer49
View More RHHBYN Executives

Board Members - roche holdings ltd-spons adr (RHHBYN)

NameBoard RelationshipsPrimary CompanyAge
Franz B. Humer 132 RelationshipsRoche Holding AG66
Severin Schwan 31 RelationshipsRoche Holding AG45
André Hoffmann 61 RelationshipsGivaudan SA54
Fritz Gerber 26 RelationshipsZurich Insurance Group AG83
Andreas Oeri 13 RelationshipsRoche Holding AG63
View All RHHBYN Board Members

Executive Committees* - roche holdings ltd-spons adr (RHHBYN)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeDame A. Deanne Shirley Julius CBE, Ph.D.(Econ) 44 Relationships4 Executives
Compensation CommitteeAndré Hoffmann 61 Relationships4 Executives
Nominating CommitteeFranz B. Humer 132 Relationships2 Executives
Corporate Governance CommitteeAndreas Oeri 13 Relationships4 Executives
View RHHBYN Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RHHBYN:MM $782.80 MXN 0.00

RHHBYN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GlaxoSmithKline PLC 1,742 GBp -31.00
Merck & Co Inc $47.33 USD +0.62
Novartis AG SFr.71.45 CHF -2.20
Pfizer Inc $29.11 USD -0.19
Sanofi €84.81 EUR -1.62
View Industry Companies
 

Industry Analysis

RHHBYN

Industry Average

Valuation RHHBYN Industry Range
Price/Earnings 21.9x
Price/Sales 4.4x
Price/Book 14.3x
Price/Cash Flow 18.0x
TEV/Sales 2.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDINGS LTD-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.